NCT06407986

Brief Summary

To evaluate the demographic characteristics of normal one-second rates population in patients with pulmonary function tests recommended by outpatient physicians. To investigate whether EIT can identify spatial and temporal heterogeneity of lung ventilation in individuals with normal one-second rates during pulmonary function testing. To investigate the distribution patterns of lung ventilation in individuals with normal one-second rates using this technique, and provide references and evidence for early screening, diagnosis, treatment monitoring, and prognostic evaluation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

May 15, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

May 6, 2024

Last Update Submit

May 27, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • regional FEV1

    They were calculated for each pixel within the lung areas by EIT data analysis

    one month

  • regional FVC

    They were calculated for each pixel within the lung areas by EIT data analysis

    one month

Secondary Outcomes (2)

  • St. George's Respiratory Questionnaire

    one month

  • regional obstructive ratio(rOR)

    one month

Study Arms (2)

Normal lung function

After using a bronchodilator, FEV1/FVC ≥70%, FEV1 and FVC ≥80% of reference values.

Diagnostic Test: pulmonary function test

Preserved ratio impaired spirometry

After using a bronchodilator, FEV1/FVC≥70%, FEV1 and/or FVC\<80% of reference values.

Diagnostic Test: pulmonary function test

Interventions

Whether the estimated value of FEV1 and FVC is greater than 80%.

Normal lung functionPreserved ratio impaired spirometry

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

After using a bronchodilator, FEV1/FVC ≥70%.

You may qualify if:

  • Age ≥18 years old. Patients who need to complete lung function tests assessed by outpatient physicians.
  • Patients willing to participate in the study and sign an informed consent form.

You may not qualify if:

  • Patients with FEV1/FVC less than 0.7 after a bronchiectasis test. Patients with a history of lung diseases other than COPD, previous lung surgery, or radiation therapy.
  • Patients who cannot be evaluated for EIT or who interfere with EIT results, such as implanted pacemakers/cardioverters.
  • Patients who cannot complete EIT or may interfere with EIT results, such as those with implanted pacemakers/defibrillators.
  • Patients who cannot complete lung function tests, such as myocardial infarction or shock in the past 3 months; severe heart failure or angina in the past 4 weeks,uncontrolled hypertension (systolic \>200mmHg, diastolic \>100mmHg),severe hyperthyroidism etc.
  • Vulnerable populations, including patients with mental illnesses, cognitive impairments, critically ill patients, illiterate, pregnant women, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sir Run Run Shaw Hospital

Hangzhou, Zhejiang, 310000, China

RECRUITING

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Respiratory Function Tests

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Huiqing Ge

    Sir Run Run Shaw Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 9, 2024

Study Start

May 15, 2024

Primary Completion

June 30, 2024

Study Completion

December 31, 2024

Last Updated

May 30, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations